Therapeutical Dose to Thyroid Remnants Determination for Low-risk Thyroid Carcinoma Patient Treated with rhTSH and 1.1 GBq 131I

被引：0
|
作者：
Solny, P. [1 ,2 ,3 ]
Kracmerova, T. [1 ,2 ,3 ]
Jonasova, L. [2 ,3 ]
Vlcek, P. [2 ,3 ]
机构：
[1] Czech Tech Univ, Dept Dosimetry & Applicat Ionizing Radiat, Fac Nucl Sci & Phys Engn, Prague, Czech Republic
[2] Charles Univ Prague, Dept Nucl Med & Endocrinol, Fac Med 2, Prague, Czech Republic
[3] Motol Univ Hosp, Prague, Czech Republic
来源：
RADIOTHERAPY AND ONCOLOGY | 2016年 / 118卷
关键词：
dosimetry; iodine therapy; 1.1; GBq;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
199
引用
收藏
页码：S97 / S97
页数：1
相关论文
共 50 条
  • [1] Thyroid remnant ablation with 1.1 GBq of 131I for outpatients
    Suzuki, K.
    Tsutsui, H.
    Suzuki, A.
    Yoshimura, M.
    Hashimoto, T.
    Uchida, K.
    Koizumi, K.
    Tokuuye, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S430 - S431
  • [2] Comparison of 1.1 GBq and 2.2 GBq Activities in Patients with Low-Risk Differentiated Thyroid Cancer Requiring Postoperative 131I Administration: A Real Life Study
    Campenni, Alfredo
    Ruggeri, Rosaria Maddalena
    Garo, Maria Luisa
    Siracusa, Massimiliano
    Restuccia, Giovanna
    Rappazzo, Andrea
    Rosarno, Helena
    Nicocia, Antonio
    Cardile, Davide
    Ovcaricek, Petra Petranovic
    Baldari, Sergio
    Giovanella, Luca
    CANCERS, 2023, 15 (09)
  • [3] Role of 131I in low-risk differentiated thyroid cancer
    Vallejo, J. A.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2023, 42 (01): : 33 - 37
  • [4] Recombinant Human Thyroid Stimulating Hormone in Thyroid Remnant Ablation With 1.1 GBq 131Iodine in Low-Risk Patients
    Rosario, Pedro Weslley
    Malard Xavier, Arthur Cezar
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2012, 35 (02): : 101 - 104
  • [5] Low Dose (1850 MBq) Versus High Dose (3700 MBq) of 131I in Ablation Therapy of Thyroid Remnants in Patients with Low Risk Differentiated Thyroid Carcinoma
    Andres Gracia, A.
    Rambalde Pecheco, E.
    Tardin Cardoso, L.
    Ayala Perez, S.
    Razola Alba, P.
    Cancer Garza, L.
    Lopez Acosta, M.
    Prats Rivera, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S537 - S537
  • [6] Differences in radioiodine biokinetics between papillary thyroid carcinoma low-risk patients treated with 1.11 GBq of 131I-NaI and high-risk patients treated with 3.7 GBq of 131I-NaI
    Minguez Gabina, P.
    Dominguez Ayala, M.
    Exposito Rodriguez, A.
    Genolla Subirats, J.
    Rodeno Ortiz de Zarate, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S261 - S261
  • [7] Comparison of 1.1 gbq and 2.2 gbq131I activities in patients with low-risk differentiated thyroid cancer requiring postoperative iodine-131 therapy.
    Campenni, A.
    Ruggeri, R.
    Garo, M.
    Raffa, A.
    Siracusa, M.
    Restuccia, G.
    Rappazzo, A.
    Rosarno, H.
    Nicocia, A.
    Cardile, D.
    Ovcaricek, P. Petranovic
    Baldari, S.
    Giovanella, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S171 - S172
  • [8] Post-surgical ablation of thyroid remnants with high-dose 131I in patients with differentiated thyroid carcinoma
    Arslan, N
    Ilgan, S
    Serdengecti, M
    Ozguven, MA
    Bayhan, H
    Okuyucu, K
    Gulec, SA
    NUCLEAR MEDICINE COMMUNICATIONS, 2001, 22 (09) : 1021 - 1027
  • [9] Treatment with 131I of thyroid remnants in a patient with papillary thyroid carcinoma and end-stage chronic renal failure
    Andres, A.
    Tardin, L.
    Santapau, A.
    Razola, P.
    Prats, E.
    Parra, A.
    Rivas, M. A.
    Ruiz, P.
    Alvarez, R.
    Camara, A.
    Banzo, J.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR, 2010, 29 (01): : 32 - 35
  • [10] Is 740 MBq of iodine 131 (131I) an ablative dose for thyroid remnants, after total thyroidectomy for low risk group patients with differentiated thyroid cancer ?
    Cuif-Job, A.
    Fieffe, S.
    Kere, D.
    Wernert, R.
    Pochart, J.
    Schvartz, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S222 - S223
12345